These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25346470)

  • 21. Diffusion-weighted magnetic resonance imaging of uterine cervical cancer.
    Liu Y; Bai R; Sun H; Liu H; Wang D
    J Comput Assist Tomogr; 2009; 33(6):858-62. PubMed ID: 19940650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
    Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
    Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
    J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of diffusion-weighted magnetic resonance imaging in assessing the response of locally advanced cervical cancer to neoadjuvant chemotherapy.
    Fu C; Bian D; Liu F; Feng X; Du W; Wang X
    Int J Gynecol Cancer; 2012 Jul; 22(6):1037-43. PubMed ID: 22683941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
    Bae JM; Kim CK; Park JJ; Park BK
    Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of histogram analysis of apparent diffusion coefficient with uterine cervical pathologic finding.
    Lin Y; Li H; Chen Z; Ni P; Zhong Q; Huang H; Sandrasegaran K
    AJR Am J Roentgenol; 2015 May; 204(5):1125-31. PubMed ID: 25905952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim YC; Lim JS; Keum KC; Kim KA; Myoung S; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW
    J Magn Reson Imaging; 2011 Sep; 34(3):570-6. PubMed ID: 21751285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quantitative analysis of diffusion-weighted magnetic resonance images during chemoradiation therapy for cancer of the cervix uteri: Prognostic role of pretreatment diffusion coefficient values].
    Kharuzhyk SA
    Vestn Rentgenol Radiol; 2015; (6):12-23. PubMed ID: 26999930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Value of Diffusion-Weighted Imaging in Combination With Conventional Magnetic Resonance Imaging for Improving Tumor Detection for Early Cervical Carcinoma Treated With Fertility-Sparing Surgery.
    Li X; Wang L; Li Y; Song P
    Int J Gynecol Cancer; 2017 Oct; 27(8):1761-1768. PubMed ID: 28930805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones.
    Kilickesmez O; Bayramoglu S; Inci E; Cimilli T; Kayhan A
    Acta Radiol; 2009 Apr; 50(3):340-7. PubMed ID: 19235579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
    Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
    Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery.
    Valentini AL; Miccò M; Gui B; Giuliani M; Rodolfino E; Telesca AM; Pasciuto T; Testa A; Gambacorta MA; Zannoni G; Rufini V; Giordano A; Valentini V; Scambia G; Manfredi R
    Eur Radiol; 2018 Jun; 28(6):2425-2435. PubMed ID: 29318432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histogram analysis of apparent diffusion coefficient for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Meng J; Zhu L; Zhu L; Ge Y; He J; Zhou Z; Yang X
    Acta Radiol; 2017 Nov; 58(11):1400-1408. PubMed ID: 28273745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Meng J; Zhu L; Zhu L; Wang H; Liu S; Yan J; Liu B; Guan Y; Ge Y; He J; Zhou Z; Yang X
    Radiat Oncol; 2016 Oct; 11(1):141. PubMed ID: 27770816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
    Jung SH; Heo SH; Kim JW; Jeong YY; Shin SS; Soung MG; Kim HR; Kang HK
    J Magn Reson Imaging; 2012 Jan; 35(1):110-6. PubMed ID: 21989997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Application of Diffusion-Weighted Magnetic Resonance Imaging in Uterine Cervical Cancer.
    Liu Y; Ye Z; Sun H; Bai R
    Int J Gynecol Cancer; 2015 Jul; 25(6):1073-8. PubMed ID: 25966933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.